Amidst a backdrop of mixed performances across global indices, Asian markets have shown varying trends, with China's stock market rallying on ample domestic liquidity while Japan's markets remain cautious due to economic uncertainties. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.
Top 10 Penny Stocks In Asia
| Name | Share Price | Market Cap | Rewards & Risks |
| Food Moments (SET:FM) | THB3.86 | THB3.81B | ✅ 4 ⚠️ 0 View Analysis > |
| JBM (Healthcare) (SEHK:2161) | HK$3.06 | HK$2.49B | ✅ 3 ⚠️ 1 View Analysis > |
| Lever Style (SEHK:1346) | HK$1.52 | HK$940.15M | ✅ 4 ⚠️ 1 View Analysis > |
| TK Group (Holdings) (SEHK:2283) | HK$2.55 | HK$2.12B | ✅ 4 ⚠️ 1 View Analysis > |
| CNMC Goldmine Holdings (Catalist:5TP) | SGD0.775 | SGD314.1M | ✅ 4 ⚠️ 2 View Analysis > |
| T.A.C. Consumer (SET:TACC) | THB4.84 | THB2.9B | ✅ 3 ⚠️ 3 View Analysis > |
| Yangzijiang Shipbuilding (Holdings) (SGX:BS6) | SGD3.06 | SGD12.04B | ✅ 5 ⚠️ 1 View Analysis > |
| Livestock Improvement (NZSE:LIC) | NZ$0.95 | NZ$135.23M | ✅ 2 ⚠️ 5 View Analysis > |
| Rojana Industrial Park (SET:ROJNA) | THB4.68 | THB9.46B | ✅ 3 ⚠️ 3 View Analysis > |
| BRC Asia (SGX:BEC) | SGD4.05 | SGD1.11B | ✅ 4 ⚠️ 1 View Analysis > |
Click here to see the full list of 976 stocks from our Asian Penny Stocks screener.
We'll examine a selection from our screener results.
EverChina Int'l Holdings (SEHK:202)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: EverChina Int'l Holdings Company Limited is an investment holding company involved in property investment and hotel operations in China and Bolivia, with a market cap of HK$1.82 billion.
Operations: The company's revenue is derived from its Agricultural Operation, generating HK$78.43 million, and its Property Investment Operation, contributing HK$29.75 million.
Market Cap: HK$1.82B
EverChina Int'l Holdings, an investment holding company, reported HK$108.18 million in sales for the fiscal year ending March 31, 2025, with a net loss of HK$40.21 million. Despite being unprofitable, it has reduced losses over the past five years at a rate of 10.1% annually and maintains a satisfactory net debt to equity ratio of 9.2%. The company's short-term assets cover its long-term liabilities but fall short for short-term liabilities. With sufficient cash runway exceeding three years if current cash flow trends persist and no significant shareholder dilution recently, it remains highly volatile with increased weekly volatility from 16% to 27%.
- Get an in-depth perspective on EverChina Int'l Holdings' performance by reading our balance sheet health report here.
- Examine EverChina Int'l Holdings' past performance report to understand how it has performed in prior years.
Venus Medtech (Hangzhou) (SEHK:2500)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Venus Medtech (Hangzhou) Inc. is involved in the research, development, manufacturing, and sale of bioprosthetic heart valves both in Mainland China and internationally, with a market cap of HK$1.92 billion.
Operations: The company generates revenue of CN¥427.25 million from its medical products segment.
Market Cap: HK$1.92B
Venus Medtech (Hangzhou) Inc. has a market cap of HK$1.92 billion and generated CN¥427.25 million in revenue from its medical products segment, although it remains unprofitable with increasing losses over the past five years at 20.9% annually. The company reported sales of CN¥187.14 million for the half-year ending June 2025, down from CN¥230.72 million a year earlier, but reduced its net loss to CN¥134.77 million from CN¥206.49 million year-over-year. With satisfactory short-term asset coverage for liabilities and no recent shareholder dilution, the stock remains highly volatile with an experienced management team averaging 3.5 years tenure.
- Dive into the specifics of Venus Medtech (Hangzhou) here with our thorough balance sheet health report.
- Learn about Venus Medtech (Hangzhou)'s historical performance here.
SinoMedia Holding (SEHK:623)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: SinoMedia Holding Limited is an investment holding company offering TV advertisement, creative content production, and digital marketing services for advertisers and agents in China and internationally, with a market cap of HK$1.23 billion.
Operations: The company generates revenue from its advertising segment, totaling CN¥462.77 million.
Market Cap: HK$1.23B
SinoMedia Holding Limited, with a market cap of HK$1.23 billion, reported half-year sales of CN¥183.37 million, down from CN¥333.12 million the previous year, yet net income rose to CN¥32.95 million from CN¥29.88 million year-over-year. The company has strong short-term asset coverage for both long-term (CN¥977K) and short-term liabilities (CN¥368.6M), and it remains debt-free with stable weekly volatility at 10%. Despite a low return on equity of 4.9%, earnings growth outpaced the media industry significantly over the past year, supported by an experienced management team averaging 12.7 years tenure.
- Click here to discover the nuances of SinoMedia Holding with our detailed analytical financial health report.
- Assess SinoMedia Holding's previous results with our detailed historical performance reports.
Make It Happen
- Embark on your investment journey to our 976 Asian Penny Stocks selection here.
- Ready For A Different Approach? We've found 18 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if SinoMedia Holding might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com